Wednesday, October 31, 2018 10:14:25 AM
https://ir.rmsmedicalproducts.com/all-sec-filings/content/0001161697-18-000509/0001161697-18-000509.pdf
below is the supplemental information concerning horton's management warrants
[SUPPLEMENTAL INFORMATION: On September 13, 2018, Horton Capital Partners Fund, LP notified RMS of its
intention to exercise the warrant, purchased on August 8, 2014 and expiring on August 8, 2019, in full at an
exercise price of $0.45 per share at a closing to take place no earlier than November 12, 2018].
Horton management continues to buy stock in the open market at these levels. This indicates a belief in the company's future and faith that the stock price will continue to appreciate.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM